These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9120670)

  • 1. Neuroprotective drug development in stroke: blood pressure and its impact.
    McCulloch J
    J Hypertens Suppl; 1996 Dec; 14(5):S131-8. PubMed ID: 9120670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of glutamic acid in the pathogenesis of stroke and the development of neuroprotective drugs.
    Evans SM; Addae JI
    West Indian Med J; 1995 Dec; 44(4):119-23. PubMed ID: 8838047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
    Lestage P; Lockhart B; Roger A
    Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroprotection by aspirin in cerebrovascular pathology].
    Lorenzo Fernández P
    An R Acad Nac Med (Madr); 2002; 119(2):311-20; discussion 320-6. PubMed ID: 12518657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against ischaemia: the basis of acute stroke therapy.
    Harrison MJ
    Curr Opin Neurol Neurosurg; 1992 Feb; 5(1):33-8. PubMed ID: 1623235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High blood pressure in acute ischaemic stroke--broadening therapeutic horizons.
    Sare GM; Geeganage C; Bath PM
    Cerebrovasc Dis; 2009; 27 Suppl 1():156-61. PubMed ID: 19342846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic advances in acute ischaemic stroke.
    Bhalla A; Rudd AG
    Int J Clin Pract; 1999 Jun; 53(4):295-300. PubMed ID: 10563075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroprotection in brain ischemia--doubts and hopes].
    Zádor Z; Benyó Z; Lacza Z; Hortobágyi T; Harkány T; Hortobágyi T
    Ideggyogy Sz; 2004 Mar; 57(3-4):81-93. PubMed ID: 15133909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of cerebral ischemia for evaluation of drugs.
    Gupta YK; Briyal S
    Indian J Physiol Pharmacol; 2004 Oct; 48(4):379-94. PubMed ID: 15907047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of ischemic stroke.
    Bentley P; Sharma P
    Pharmacol Ther; 2005 Dec; 108(3):334-52. PubMed ID: 16135384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertension and its therapy in the acute phase of stroke].
    Káposzta Z; Rácz K
    Ideggyogy Sz; 2009 May; 62(5-6):164-7. PubMed ID: 19579664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
    Di Mascio R; Marchioli R; Tognoni G
    Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal blood pressure circadian rhythm in acute ischaemic stroke: are lacunar strokes really different?
    Castilla-Guerra L; Espino-Montoro A; Fernández-Moreno MC; López-Chozas JM
    Int J Stroke; 2009 Aug; 4(4):257-61. PubMed ID: 19689751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
    Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
    Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
    Candelario-Jalil E
    Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus.
    Jeffs B; Clark JS; Anderson NH; Gratton J; Brosnan MJ; Gauguier D; Reid JL; Macrae IM; Dominiczak AF
    Nat Genet; 1997 Aug; 16(4):364-7. PubMed ID: 9241273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The past and future of neuroprotection in cerebral ischaemic stroke.
    Shuaib A; Hussain MS
    Eur Neurol; 2008; 59(1-2):4-14. PubMed ID: 17917451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current situation of neuroprotection in stroke].
    Martínez-Vila E; Irimia-Sieira P; Gállego-Culleré J
    Rev Neurol; 1999 Sep 16-30; 29(6):526-36. PubMed ID: 10584268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental models of cerebral ischemia].
    Prieto-Arribas R; Moreno-Gutiérrez A; Simal-Hernández P; Pascual-Garvi JM; Matías-Guiu J; Roda JM; Barcia-Albacar JA
    Rev Neurol; 2008 Oct 16-31; 47(8):414-26. PubMed ID: 18937203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.